Oncology & Cancer

Studies review relationship between immune system and cancer

The last ten years have seen a renewed interest in how cancer evades the immune system and how white blood cells can be used therapeutically to help patients, even with late-stage diagnoses. In an April 13 joint special issue ...

Oncology & Cancer

Neurotransmitter might improve cancer treatment: study

Doses of a neurotransmitter might offer a way to boost the effectiveness of anticancer drugs and radiation therapy, according to a new study led by researchers at the Ohio State University Comprehensive Cancer Center – ...

Oncology & Cancer

Cancer immunotherapy a top trend in health care in 2015

This year has been a momentous year in health care, and, as some news outlets like Boston's WBUR radio are reporting, one of the biggest successes is the explosion of cancer immunotherapy. The American Association for Cancer ...

Oncology & Cancer

Researchers map paths to cancer drug resistance

A team of researchers led by Duke Cancer Institute has identified key events that prompt certain cancer cells to develop resistance to otherwise lethal therapies.

Medical research

Hormone reduces risk of heart failure from chemotherapy

Recent studies have shown that the heart contains cardiac stem cells that can contribute to regeneration and healing during disease and aging. However, little is known about the molecules and pathways that regulate these ...

Oncology & Cancer

The path to personalized cancer treatment

In the largest study of its kind, researchers have profiled genetic changes in cancer with drug sensitivity in order to develop a personalised approach to cancer treatments. The study is published in Nature on Thursday 29 ...

Oncology & Cancer

Energy network within cells may be new target for cancer therapy

Mitochondria, tiny structures within each cell that regulate metabolism and energy use, may be a promising new target for cancer therapy, according to a new study. Manipulation of two biochemical signals that regulate the ...

Oncology & Cancer

Antifungal drug delays need for chemo in advanced prostate cancer

The oral antifungal drug itraconazole, most commonly used to treat nail fungus, may keep prostate cancer from worsening and delay the need for chemotherapy in men with advanced disease. Details of the finding, from a clinical ...

page 1 from 4